Recent studies from our laboratory have shown that treating BN rats with HgCl2 causes a decrease in peripheral RT6+ T-lymphocytes, a change that coincides with the appearance of circulating autoantibodies to renal antigens (17) . We have proposed that autoimmune kidney disease induced by mercury in genetically susceptible rats may be a consequence of interactions between this metal and a subset of regulatory (RT6+?) T-cells. In contrast, Lewis (LEW) rats are resistant to the autoimmune effects of mercury and reportedly develop a subpopulation of suppressor T-lymphocytes (18, 19) . Therefore, it was of interest to compare the effects of mercury on lymphocyte subpopulations from BN, LEW, and (BN x LEW) F1 rats. The hybrids between the mercury-susceptible BN and the mercury-resistant LEW strain are susceptible to the autoimmune effects of HgCl2, a trait inherited in a dominant fashion (4) . We show here that LEW rats injected with HgCI2 do not have significant decreases in RT6+ T-lymphocytes or detectable autoimmune responses. Instead, both BN and (BN x LEW) F1
hybrid rats experience autoimmune responses to renal antigens as well as similar changes in RT6+ T-cells after mercury treatment.
Methods
We obtained 107 female rats [39 LEW, 36 (BN), and 32 (BN x LEW) Fl hybrids, hereafter referred to as F, hybrids] from a commercial source (Harlan Sprague Dawley, Indianapolis, IN). All animals were housed in plastic cages with wood shavings, in an automated light cycle environment (12:12 hr) and received standard rat diet and water ad libitum. Treatment of all rats followed the standard National Institutes of Health guidelines: light ether anesthesia was used for all procedures, including bleeding from the retro-orbital plexus or exsanguination followed by transection of the thoracic aorta at the termination of the experiments.
Previous studies have shown that treatment with mercury in its various chemical forms, using different routes of administration (subcutaneous injection, oral ingestion, inhalation), results in autoimmune responses to a variety of antigens (7) (8) (9) (10) . Relatively low doses of mercury have been found to be effective in both rats and mice; for example, the immunotoxic effects of If -HgCI2 occur in BN rats at doses (3-25 ,g/100 g body weight) that are much lower than those causing the common nephrotoxic effects (11, 12, Bigazzi et al.,  unpublished data). However, in the experiments reported here, we used higher levels of HgCl2 (100 ,ug/100 g body weight) to replicate the doses used in previous studies of BN and LEW rats (17, 18, 20) . BN, LEW, and F1 rats were randomly divided into experimental and control groups and treated with mercury or water, respectively, as previously described (17) . We injected 80 experimental rats (31 LEW, 25 BN, and 24 F1 hybrids) subcutaneously on the abdomen with 0.1 ml of a mercuric chloride solution (HgCl2, 1 mg/ml) per 100 g body weight. We dissolved HgCl2 in distilled water and recorded the pH before use (range 3.9-4.2). Rats were injected under light ether anesthesia. We injected rats three times a week for 2 weeks, for a total administration of 600 ,ug HgCI2/ 100 g body weight/rat. Four LEW rats died under ether anesthesia and one F1 hybrid injected with mercury died on day 12 of mercury treatment: these animals are not included in the Results section. We anesthetized and injected 27 control rats (8 LEW, 11 BN, and 8 F1 hybrid of same age and weight as those injected with mercury) with distilled water at pH 4.2 (acidified by adding 0.01 N HCI) following the same regimen.
ELISA for circulating autoantibodies to renal GBM and anti-laminin antibodies was performed as previously described (17) . In brief, we incubated sera from mercury-treated and control rats in ELISA plates that had been coated previously with rat GBM or mouse laminin (500 ng/well). After incubation and washing, horseradish peroxidase-conjugated rabbit antibodies to rat IgG Uackson ImmunoResearch Laboratories, Inc., West Grove, PA) were used to detect the binding of rat anti-GBM to GBM (or anti-laminin to laminin). We read plates using a Titertek ELISA Reader at OD414.
We determined rat IgG bound to renal GBM and tubular basement membrane (TBM) by direct immunofluorescence as previously described (17) . In brief, cryostat sections of rat kidney were stained with fluoroscein isothiocyanate (FITC)-conjugated rabbit antibodies to rat IgG (Sigma Chemical Company, St. Louis, MO) diluted 1:20 in phosphate-buffered saline. We read the sections using a Leitz Dialux fluorescence microscope equipped with epi-illumination.
As previously described (17) , spleen, lymph node, and thymus cell suspensions were obtained by gently pressing the tissues through a stainless-steel screen (50 mesh). The six proximal cervical lymph nodes were recovered for total cell counts and subset analysis in all experiments. We washed the cells in two changes of cold medium (RPMI 1640) and determined cell viability by trypan blue exclusion. Cell suspensions were labeled with anti-RT6.2 or anti-RT6.1 rat monoclonal antibodies (mAb) and developed for immunofluorescence with an F(ab')2 fragment of an FITC-conjugated goat anti-rat IgG (heavy and light chain specific; Caltag Laboratories, San Francisco, CA). Controls included the FITC conjugate alone and "irrelevant" primary rat mAb developed with the same secondary reagent: values obtained from these controls represent surface Ig-positive (B) lymphocytes and were subtracted from the counts of RT6+ cells. When cells were labeled with mouse mAb directed against other cell surface markers (CD4, CD5, CD8, etc., see below), we developed them with an F(ab')2 fragment of an FITC-conjugated goat anti-mouse IgG antibody that had been absorbed by affinity chromatography on a rat IgG column to remove cross-reacting antibodies. Controls routinely included the FITC conjugate alone and irrelevant mouse mAb. Cell suspensions were fixed before flow cytometry using saline-buffered 10% formalin and then analyzed using a fluorescence-activated cell sorter IV (Becton Dickinson, Mountain View, CA), according to relative low-angle light scatter and relative fluorescence intensity as described previously (21, 22) . We excluded dead cells and contaminating red blood cells from analysis by electronic gating. At least 50,000 nucleated cells were analyzed for relative fluorescence intensity.
Hybridoma cell lines secreting mAb to the RT6.1 (clone DS4.23) and RT6.2 (clone 6A5) alloantigens are maintained in our laboratory (21, 22 RT6+ T-cell subsets are severely decreased in diabetes-prone BB rats (i.e., animals that spontaneously develop insulin-dependent diabetes mellitus, both clinically and biochemically analogous to human diabetes mellitus) (26, 27) . Different lines of BB rats have been developed, one called "diabetes-prone" (DP) and one called "diabetes-resistant" (DR). In vivo depletion of RT6+ cells induces diabetes in 50% of DR BB rats (28) . Lymphocyte transfers from DR to DP rats prevent diabetes mellitus, and this protection is associated with the persistence of donor-origin RT6+ T-cells (29) . In addition, concanavalin A-activated spleen cells from RT6-depleted PVG or Yoshida rats can transfer insulitis and/or thyroiditis to histocompatible athymic recipients (30) .
We We obtained the total number of RT6+ lymphocytes from their percentage of the total cell numbers in spleen or lymph nodes. Then we calculated the total number of RT6-cells by subtracting the total number of RT6+ lymphocytes from total T (CD5+) cell numbers. Finally, we obtained the RT6-to RT6+ ratio by dividing the total number of RT6.1-or RT6.2-Tlymphocytes by the total number of RT6. 1+ or RT6.2+ lymphocytes.
All ELISAs were performed in duplicate, and the data obtained are expressed as means ± SEM. Flow cytometric analysis was performed on single samples from each rat, and the data from all experimental (or control) groups are expressed as means ± SEM. We statistically evaluated results obtained by ELISA and flow cytometry by one-way analysis of variance (ANOVA), followed by post-hoc means tests (Fisher's Protected Least Significance Difference, Scheffe's S, Games-Howell, and Dunnett's multiple comparison procedures). Two computer programs (StatView II and SuperANOVA, Abacus Concepts, Inc., Berkeley, CA) were used for this purpose.
Results

Autoimmune Responses to Renal Antigens
We first examined the effects of mercury in two matching groups of LEW and BN rats, treated with mercury ("experimental") or injected with water ("control") and sac- There were no significant differences in percentage of RT6+ cells from the spleens of control and experimental LEW rats on days 12, 16, and 23 (Table 2) . Values for day 30 showed a moderate increase (26%, p = 0.0233). There were also no percentage changes in lymph nodes for days 12 and 30, but a slight decrease was observed on days 16 (12%, p = 0.0565) and 23 (16%, p = 0.0438). The total number of RT6. 1+ spleen lymphocytes showed a moderate increase on each day of treatment (day 12 = 92%, p = 0.0083; day 16 = 83%, p = 0.0045; day 23 = 112%, p = 0.0018; day 30 = 92%, p = 0.0083), whereas lymph node cells had a significant change only on day 16 (185% increase, p = 0.0001). The ratio of RT6-to RT6+ cells did not usually vary in experimental animals versus controls, except for a modest increase (37%, p = 0.0186) observed in lymph node cells only on day 23. As shown in Figure 2 , which compares values obtained from animals of different strains, there was no significant change in the RT6 ratio of LEW rats sacrificed on day 16 .
The percentage of T-cells did not vary significantly in experimental versus control rats. Table 2 provides data obtained with mAb OX-19 (anti-CD5), but similar results were also obtained with mAb R7.3 (anti-TCRoa). On the other hand, total numbers of T-cells had increases comparable to those observed in total cell numbers (data not shown). In the spleen, T-cell numbers were higher on days 12 (99%, p = 0.0442), 16 (65%, p = 0.0425), and 23 (107%, p = 0.0363). In lymph nodes they increased only on days 16 (224%, p = 0.004) and 23 (48%, p = 0.0763). Percentages of CD8+ and CD4+ lymphocytes varied little either in spleen or lymph nodes. Total numbers of CD8+ T-cells did not change significantly in the spleen but were 258% higher in lymph nodes (p = 0.0009) Table 3 , the number of rease of total cell spleen cells in experimental BN rats was after 16 days of considerably higher than in controls, a difh BN (spleen, p= ference that was statistically significant )des,p=0.0001).
(218%, p = 0.0033). A more striking increase in total cell numbers (860%, p = 0.0001) occurred in cervical lymph nodes (Table 3) , confirming previous observations of hyperplasia in peripheral lymphoid tissues from BN rats exposed to mercury (17, (31) (32) (33) .
After 2 weeks of mercury treatment, the percentage of RT6+ cells in lymph nodes was significantly decreased as compared to controls (100%, p = 0.0009), whereas spleen cells had a less marked change (55%, p = 0.0062). The total Water number of RT6.2+ lymphocytes of experimental BN rats was moderately increased * Mercury in the spleen (78%, p = 0.0578), but was higher in lymph nodes (307%, p = 0.0033). On the other hand, the total number of RT6.2-cells was greatly increased and proportionally more than that of RT6.2+ cells (332%, p = 0.0084 in the spleen; 572%, p = 0.0602 in lymph nodes). As a consequence, the ratio of RT6-to RT6+ positive cells was higher both in lymph nodes and spleens of experimental BN rats (Fig. 2) .
In the spleen, there was no significant change in the percentage of T-cells in experimental versus control rats (p = r6+T-lymphocytes 0.2643), but the total numbers of T-cells treated LEW rats increased by 173% after mercury treatment (p = 0.0045). Similarly, the percentage of spleen CD8+ lymphocytes did not treatment of show major changes (p = 0.3048), but their est but signifitotal number was increased (316%, p = r of spleen and 0.0313). In contrast, CD4+ cells were prelymph node cells, and as a consequence most subpopulations of lymphocytes were numerically increased. There were only slight and sporadic changes in the percentage of RT6+ T-cells, but their numbers were higher in experimental than in control animals. The ratio between RT6-and sent in a lower percentage in experimental BN (38% change, p = 0.0004) but showed slightly higher numbers (1 19% As shown in Table 3 and Figure 1 , the total number of spleen cells in experimental F1 rats was increased by 78% as compared to controls (p = 0.01). A more striking increase in total cell numbers (1315%, p = 0.0001) occurred in cervical lymph nodes (Table 3) .
The percentage of cells expressing the RT6 phenotypes was significantly decreased in both spleens and lymph nodes of experimental animals as compared to controls (Table 3 ). In the spleen, percentages of RT6.1+ and RT6.2+ were lower by 110% and 1 9% (p = 0.0001 for both). Similar reductions were observed in lymph nodes (92% and 102% change, p = 0.0001 for both). The total number of RT6.1+ and RT6.2+ spleen lymphocytes did not show significant changes, but RT6-cells were increased (137%, p = 0.0016 for RT6.1-and 296%, p = 0.0001 for RT6.2-). Therefore, the ratios of RT6-to RT6+ spleen cells were increased by 197% for RT6.1 and 385% for RT6.2 (p = 0.0001 for both; Fig. 2) . In cervical lymph nodes of experimental rats, the total number of RT6.1+ and RT6.2+ lymphocytes was significantly increased (623% and 587%, p = 0.0001 for both). However, RT6-cells were present in even greater numbers (1114% change for RT6.1-and 2372% for RT6.2-, p = 0.0001 for both), resulting in altered ratios of RT6-to RT6+ cells (Fig.  2 ). An increase of 89% was observed for RT6.1-/RT6.1+ (p = 0.0802) and 258% for RT6.2-/RT6.2+ (p = 0.0064).
In the spleens of experimental F, animals, we observed a 24% decrease in the percentage of T-cells (p = 0.0001) and a 41% increase in T-cell numbers (p = 0.0766) as compared to controls. Both percentage and total numbers of spleen CD8+ lymphocytes were increased (35%, p = 0.0001 and 140%, p = 0.0021). In contrast, CD4+ cells were present in a lower percentage in the spleen of experimental Fl rats (29% change, p = 0.0063), but their numbers were not significantly higher (p = 0.1156). Both percentage and number of spleen B-cells were increased (36%, p = 0.0001 and 142%, p = 0.0038). Lymphocytes from cervical lymph nodes gave similar patterns, with decreases in percentage of T-and CD4+ cells (55% and 68% change, p = 0.0001 in both cases) and striking increases in their numbers (816% and 732%, p = 0.0001 for both). On the other hand, lymph node CD8+ cells presented increases both in percentage and numbers (64%, p = 0.0004 and 2393%, p = 0.0001). Finally, there was a definite increase of B-lymphocytes in the lymph nodes of experimental F1 rats: their percentages were 154% (p = 0.0001) higher, and their numbers rose by 3665% (p = 0.0001).
In summary, treatment of F1 hybrids with mercury resulted in hyperplasia of peripheral lymphoid tissues similar to that observed in BN rats under the same circumstances. In addition, exposure to mercury was followed by significant decreases of RT6+ and increases of RT6-cells. The resulting changes in the ratio between these lymphocyte subpopulations revealed that mercury had altered their balance. Thus, F1 hybrids exhibited the same behavior of their mercury-susceptible parental strain (BN), both in their autoimmune responses to renal antigens and changes in lymphocyte subpopulations.
Discussion
The existence of T-suppressor cells is one of the most controversial topics of immunology. However, Todd and Steinman (34) state that "suppressor cells are back in fashion, since they refuse to go away and crop up repeatedly in autoimmune diseases as a plausible explanation for peripheral tolerance." Previous studies relied exclusively on a few markers (e.g., CD4 and CD8) as representative of functional (helper/inducer versus suppressor/ cytotoxic, respectively) activities, which may explain both controversial results and lack of correlations between T-cell subsets, severity of autoimmune disease, and/or kinetics of autoimmune responses. The recent demonstration of T-cell heterogeneity, including various functional phenotypes of CD4+ cells (35) (36) (37) (38) , has led to more refined dissections of the complex regulatory network. In rats, peripheral Tcells differ in their expression of various membrane determinants, i.e., CD4, CD8, QCA-1, Thy-1, CD45RC, and RT6. Thus, combining these markers allows the identification of a large number of phenotypically different subsets of peripheral Tlymphocytes (39) . Previous investigations in our laboratory have demonstrated that BN rats repeatedly injected with mercuric chloride experience a relative decrease of peripheral RT6.2+ T-lymphocytes and an altered ratio of RT6-to RT6+ T-cells (1/). These changes coincide with the appearance of circulating autoantibodies to renal Environmental Health Perspectives
antigens (e.g., laminin). In the present study we extended our phenotypic analysis to rats of another strain (LEW) and examined additional numbers of BN rats as well as F1 hybrids between BN and LEW. We have confirmed that LEW and BN rats differ in their responses to the administration of HgCI2. It was known that LEW rats do not develop renal autoimmunity after mercury treatment (4). However, there was no information on the behavior of RT6+ T-cells after exposure of LEW rats to mercury, and it is of interest that their percentage did not significantly decrease. Numbers of RT6+ cells were actually higher in both spleens and lymph nodes of experimental rats, with increases that reached statistical significance. In the spleen, the ratio between RT6-and RT6+ T-lymphocytes showed a modest decrease only on day 30, whereas in the lymph nodes it was increased only on day 23, suggesting that treatment with mercury did not have consistent effects on this lymphocyte subpopulation. The lack of changes in this natural balance may explain the LEW resistance to the autoimmune effects of this metal. On the other hand, we confirmed our initial findings that BN rats injected with HgCl2 experience autoimmune responses to renal antigens as well as a decrease in the percentage of RT6+ cells. In spite of strikingly higher total numbers of spleen and lymph node cells, the numbers of RT6+ cells did not proportionally increase, resulting in an altered balance between RT6-and RT6+ T-lymphocytes (Fig. 2) . This mercury-induced effect is quite similar to our previous results from three different groups of BN rats, which showed a definite decrease in the number of RT6+ spleen cells in one group and relative decreases in the other two (e.g., a 6% increase versus controls, in spite of a 52% increase in total cell numbers) (17) . Dif (Fig. 2 ). Exposure to mercury had other immunotoxic effects on peripheral lymphoid tissues (see Fig. 1 ). Total cell numbers increased in the spleen and lymph nodes of all experimental rats; however, the increase was rather modest in LEW rats as compared to that observed in BN rats.
Changes in the spleens of Fl hybrids were intermediate between those of the parental strains, whereas numbers in lymph nodes were much higher. Other investigators have previously reported that spleens and lymph nodes were not much enlarged in LEW rats injected with HgCI2 and there were no major changes in totaf cell numbers (18, 33, 41) . However, the modest increases we observed may be easily explained by differences in age and weight of our LEW rats or the use of a different substrain, possibly more susceptible to mercury effects. The marked proliferation of BN spleen and lymph node cells after treatment with HgCl2 has been previously noted by various investigators (17, 18, 32, 33, 41) . On the other hand, the lymphadenopathy and splenomegaly of F1 hybrids have not received much attention.
In addition to numerical increases of spleen and lymph node cells, we also noticed changes in most lymphocyte subpopulations. For example, flow cytometry of lymph nodes from experimental LEW rats revealed a percentage decrease of Bcells on day 12 and an increase on days 16 and 23. Parallel percentage changes of Ia' cells were also observed on the same days. The percentage of T-cells in the same lymph nodes never varied significantly and that of CD8+ cells was increased only on day 23 . In contrast, CD4+ cells differed on each day of treatment, with a percentage increase on day 12 and decreases thereafter. Values for the spleen were more constant, with the only significant percentage changes noted on day 30 , when there was a decrease of B-and Ia' cells. On the other hand, total cell numbers of almost all subsets were higher on days 12, 16 , and 23 of treatment, proportional to the moderate increase in total cell numbers. Data for experimental BN rats were obtained only on day 16 , i.e., at a time when their autoimmune responses to renal antigens are at their peak (17) . B-cell percentages and numbers were both higher than in controls, whereas T-cell percentages de-creased and numbers increased. Percentages and numbers of CD8+ T-lymphocytes were increased. In contrast, percentages of CD4+ T-cells decreased and their numbers increased. Almost identical changes were observed in spleen and lymph nodes obtained from F1 hybrids on day 16 of treatment with HgCl2.
Of particular interest is our finding that both percentage and total numbers of CD8+ T-lymphocytes did not show consistent and significant increases in the spleens of experimental LEW rats. In the lymph nodes, CD8+ cells increased in percentage only on day 23 T-cells in LEW rats on days 14, 28, and 35 of mercury treatment. The same group reported that the administration of HgCI2 to LEW rats for 2 weeks before immunization with certain autoantigens had immunosuppressive effects on the experimental induction of autoimmunity (e.g., Heymann's nephritis and EAE) (19, 42) . As far as BN rats are concerned, sequential studies of peripheral blood lymphocyte populations during HgCI2 treatment have shown a transient decrease in the percentage of CD8+ T-cells before the appearance of serum anti-GBM antibodies, followed by elevated levels of these cells during down-regulation of the response (43). Aten et al. (32) also noted that CD8 levels were higher in BN rats on day 21 than on day 0. These observations led to the suggestion that CD8+ cells, which at that time were still defined as "suppressor/cytotoxic" T-lymphocytes, might have an immunoregulatory role in both LEW and BN rats. Differences in techniques of phenotypic analysis and the use of various substrains of rats may explain the discrepancies between the data available in the literature. In any case, considerable doubts have later been raised about the existence of T-suppressor cells in general and the immunosuppressive properties of CD8+ T-lymphocytes in particular. Our findings suggest that increases of CD8+ T-cells may actually have no major role in the lack of autoimmune responses or the down-regulation of renal autoimmunity observed in LEW and BN rats, respectively, after mercury treatment.
Finally, our data underline the importance of a complete and detailed phenotypic analysis of lymphoid cells in studies of immunotoxicity and xenobiotic-induced autoimmunity. Traditional markers such as CD4 and CD8 may not be sufficient to characterize different subpopulations of Tcells, in view of the heterogeneity demonstrated by functional studies (38) . The use of additional surface markers (e.g., the RT6 alloantigens) together with cytokine profiles of T-cell clones may be necessary for a better understanding of immunoregulatory processes. T-cells of the RT6 phenotype are known to be severely decreased in spontaneously hyperglycemic diabetesprone BB/Wor rats, and their deficiency may be an important predisposing factor in susceptibility to insulin-dependent diabetes mellitus. It has also been suggested that RT6+ T-cells have a regulatory role in selftolerance (44) . The parallel changes of RT6+ T-lymphocytes observed in both BN and F1 hybrids as well as the opposite behavior detected in LEW rats also suggest a regulatory role of RT6 lymphocytes. The obvious question then arises: Are there equivalents for the RT6 marker in humans? To our knowledge, none have been reported to date. However, two recent studies have shown an abnormally high proportion of CD4+ T-cells of the CD45RA+ phenotype in patients with insulin-dependent diabetes mellitus or mixed connective tissue disease (45, 46) . These results still need to be confirmed, and their functional significance remains to be determined (47) . However, they suggest that phenotypic and functional changes first observed in rat models of autoimmunity may have similar, if not identical, counterparts in human disease.
In conclusion, on the basis of the results presented in this paper we propose the hypothesis that there are both endogenous and exogenous components of mercury-induced autoimmunity. The first component, genetically determined, constitutes the "terrain" of the individuals exposed to the xenobiotic and comprises TCR, MHC, and an immunoregulatory network based on a delicate balance between cells with suppressor (e.g., RT6+ Tlymphocytes) and helper activities. The exogenous component is represented by an environmental factor, e.g., mercury, capable of altering the balance within the immunoregulatory network. All these elements must be present and interact for autoimmunity to occur. The rat models described in this paper lend themselves to experimental manipulations, currently ongoing in our laboratory, to dissect the role of these various components in autoimmunity induced by mercury.
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